Construction of a robust fluorescent probe for the rapid evaluation of natural products' inhibition of Alzheimer's disease
Analytica Chimica Acta · 2026-12 · 1426 · 346374
DOI: 10.1016/j.aca.2026.346374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-12. Verfasst von Xiaofang Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, 410004, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Fluorescent Dyes, Biological Products. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Science and Technology Program of Hunan Province, Hunan Provincial Innovation Foundation for Postgraduate, Key Project of Research and Development Plan of Hunan Province.
Themen: Demenz
Abstract (Originalsprache)
Peroxynitrite (ONOO-) is a key oxidative stress biomarker for Alzheimer's disease (AD), and elevated levels of ONOO- in the brain directly reflect the extent of oxidative stress-induced damage in AD. To enable in situ real-time monitoring of ONOO-, this study designed and synthesized a ratiometric near-infrared fluorescent probe (BF) based on a D-π-A framework. The probe BF emits near-infrared fluorescence; upon interaction with ONOO-, BF's intrinsic ICT is weakened, causing a blue shift in its emission and resulting in a red-to-green ratio change. When applied to PC12 cells and AD model mice, BF enables real-time ratiometric imaging monitoring of changes in ONOO- levels within the cells and the mouse brain. Furthermore, through molecular docking, neobavaisoflavone (with curcumin as a control) was screened as an intervention drug; BF successfully monitored the real-time dynamic downregulation of ONOO-, and the signal recovery in the neobavaisoflavone group was superior to that in the curcumin group and the model group. This study established a rapid evaluation platform centered on real-time imaging with near-infrared ratiometric probes, which not only enables in situ dynamic monitoring of AD-related ONOO- but also provides an intuitive and reliable visualization method for the rapid assessment of the efficacy of anti-AD candidate drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, 410004, China.
- Rehabilitation Medicine Department, Affiliated Changsha Central Hospital, University of South China, Hunan, 410004, China.
- College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, 410004, China. Electronic address: zhouly0817@163.com.
- College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, Hunan, 410004, China. Electronic address: zhanglin840514@126.com.
Förderung
- Science and Technology Program of Hunan Province
- Hunan Provincial Innovation Foundation for Postgraduate
- Key Project of Research and Development Plan of Hunan Province
- Central South University of Forestry and Technology
Zitieren
APA
Xu, X., Xu, X., Zhou, L., Wang, W., Ouyang, M., Zheng, J., & Zhang, L. (2026). Construction of a robust fluorescent probe for the rapid evaluation of natural products' inhibition of Alzheimer's disease. Analytica Chimica Acta, 1426, 346374. https://doi.org/10.1016/j.aca.2026.346374
Vancouver
Xu X, Xu X, Zhou L, Wang W, Ouyang M, Zheng J, et al. Construction of a robust fluorescent probe for the rapid evaluation of natural products' inhibition of Alzheimer's disease. Analytica Chimica Acta. 2026;1426:346374. doi:10.1016/j.aca.2026.346374
BibTeX
@article{Xu2026,
author = {Xu, Xiaofang and Xu, Xiufeng and Zhou, Liyi and Wang, Wanyi and Ouyang, Min and Zheng, Jiaxing and Zhang, Lin},
title = {Construction of a robust fluorescent probe for the rapid evaluation of natural products' inhibition of Alzheimer's disease},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1426},
pages = {346374},
doi = {10.1016/j.aca.2026.346374}
}
EUVIMED